# Trade Mark Journal No.2025/041 10 October 2025

## UK00004272593 2 October 2025 (5)

International priority date claimed: 9 June 2025 (Republic of Korea) (40-2025-0098402)

Class 5
  Pharmaceuticals for human use; monoclonal antibodies for medical use; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of hidradenitis suppurativa; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of autoimmune diseases.

CELLTRION, INC.

Representative: Agile IP LLP